Clinical Trials
59 trialsA Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Exelixis
Natural History Study of Patients With Neurofibromatosis Type 2
National Institutes of Health Clinical Center (CC)
Cognitive Status After Removal of Skull Base Meningioma
Ohio State University
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
Ohio State University Comprehensive Cancer Center
CSF-IMR
Medical University of Warsaw
NEURO-SUTURE
Medical University of Warsaw
Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
University of California, San Francisco
SRS-AIM
University of California, San Francisco
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Baptist Health South Florida
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Perspective Therapeutics
MIRAGE
Istituto Oncologico Veneto IRCCS
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Alliance for Clinical Trials in Oncology
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NRG Oncology
INTUITT-NF2
Massachusetts General Hospital
NK Cell Therapy for Malignant Solid Brain Tumors
Peking University Third Hospital
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Mayo Clinic
LUPARPED
Fundación de investigación HM
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Nationwide Children's Hospital
Abemaciclib in Newly Diagnosed Meningioma Patients
St. Joseph's Hospital and Medical Center, Phoenix
MOLI
University Hospital Heidelberg
Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
Weill Medical College of Cornell University
SIMPLIF-AI
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
HiPPI
Emory University
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
GT Medical Technologies, Inc.
MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
Shengjing Hospital
3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features
Shengjing Hospital
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
Emory University
MIND
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Evaluation of the CONVIVO System
Dartmouth-Hitchcock Medical Center
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
Jonsson Comprehensive Cancer Center
Robot-Assisted Neurovascular Intervention
Navigantis Inc.
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Jazz Pharmaceuticals
LIBERATE
University Health Network, Toronto
DOMINO-START
Weill Medical College of Cornell University
HOBSCOTCH-CA
Dartmouth-Hitchcock Medical Center
PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI
Maastricht Radiation Oncology
LUMEN-1
European Organisation for Research and Treatment of Cancer - EORTC
PRIDE
Tata Memorial Centre
A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
Peking Union Medical College Hospital
EURJMT
University Hospital Muenster
MenQOL
Centre Hospitalier St Anne
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Northwestern University
CANCER-COG
Centre Francois Baclesse
e-men
St. Olavs Hospital
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
University of California, San Francisco
Endo-Olfact
Universitaire Ziekenhuizen KU Leuven
PROMENADE
University Hospital, Basel, Switzerland
23Men
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ELUMEN
Central Hospital, Nancy, France
SPIDER-MEN
Centro di Riferimento Oncologico - Aviano